This tender is from the country of Korea in Asian region. The tender was published by Chosun University on 01 Jun 2026 for Efficacy and specificity optimization and new derivative design-synthesis consignment service for 『Development of new anticancer lead substances that inhibit HSPA1L-METTL21A protein-protein interactions (PPIs), a new drug target biomarker for recurrent and metastatic colorectal cancer』. The last date to submit your bid for this tender is 13 Jun 2026. This tender is for the companies specializing in General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents, Antibiotics and chemotherapeutics for dermatological use, Antineoplastic and immunomodulating agents, Antineoplastic agents, Molecular diagnostic and similar sectors. Tender Impulse ID: 13103602.
Tender Organisation:
Chosun University
Tender Service:
Worldwide
Tender Region:
Tender Country:
Tender CPV:
33650000 : General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents
33631400 : Antibiotics and chemotherapeutics for dermatological use
33652000 : Antineoplastic and immunomodulating agents
33652100 : Antineoplastic agents
98127347 : Molecular diagnostic
Tender Document Type:
Tender Notice
Tender Description:
Efficacy and specificity optimization and new derivative design-synthesis consignment service for 『Development of new anticancer lead substances that inhibit HSPA1L-METTL21A protein-protein interactions (PPIs), a new drug target biomarker for recurrent and metastatic colorectal cancer』
Tender Bidding Type:
Tender Notice No:
Tender Document:
Looking for more tenders like this one in General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents, Antibiotics and chemotherapeutics for dermatological use, Antineoplastic and immunomodulating agents, Antineoplastic agents, Molecular diagnostic? With over 11 million global procurement opportunities and new tenders added daily, Tender Impulse is your gateway to international and local contracting success. Whether you're targeting the sector in Korea, or expanding across regions, we provide live, accurate, and relevant updates every day.
Our platform sources tenders from:
Every day, we add hundreds of new RFPs, RFQs, EOIs, and contract awards across multiple sectors and geographies. This tender from Korea is just a sample of what's available right now.
Tender Impulse covers:
Each listing is categorized using CPV codes like 33650000, 33631400, 33652000, 33652100, 98127347, enabling precise filtering. Search by:
While you're viewing a tender in Korea, Tender Impulse offers access to tenders across:
Tender Impulse provides more than listings:
Thousands of new tenders are added daily-across countries, sectors, and CPV codes. With Tender Impulse, you gain strategic insight, timely alerts, and a competitive edge.
Request a free live demo now to unlock tenders customized to your , Korea, and General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents, Antibiotics and chemotherapeutics for dermatological use, Antineoplastic and immunomodulating agents, Antineoplastic agents, Molecular diagnostic categories.
Your action completed successfully.